{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:54:15Z","timestamp":1792011255791,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":31,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["J4-4563"],"award-info":[{"award-number":["J4-4563"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P4-0176"],"award-info":[{"award-number":["P4-0176"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["899619"],"award-info":[{"award-number":["899619"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101059842"],"award-info":[{"award-number":["101059842"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"BMBF Bonn","doi-asserted-by":"publisher","award":["03ZU1201BA"],"award-info":[{"award-number":["03ZU1201BA"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.09.033","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:55:49Z","timestamp":1790610949000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoupling reactogenicity from efficacy enables safer mRNA vaccines, AAV gene delivery, and in vivo base editing"],"prefix":"10.1016","author":[{"given":"Du\u0161ko","family":"Lain\u0161\u010dek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160pela","family":"Malen\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida","family":"Forstneri\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Golob-Urbanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Orehek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jure","family":"Bohinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateja Man\u010dek","family":"Keber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timotej","family":"Soto\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Esih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pe\u010dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelica","family":"Pantovi\u0107-\u017dalig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Ben\u010dina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Bester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Protzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6337-5251","authenticated-orcid":false,"given":"Roman","family":"Jerala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.09.033_bib1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.178.4061.648.a","article-title":"Gene therapy for human genetic disease?","volume":"178","author":"Neufeld","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.09.033_bib2","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.09.033_bib3","doi-asserted-by":"crossref","first-page":"e10374","DOI":"10.1002\/btm2.10374","article-title":"RNA therapeutics in the clinic","volume":"8","author":"Curreri","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.09.033_bib4","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1017\/erm.2025.10","article-title":"Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects","volume":"27","author":"Cetin","year":"2025","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ymthe.2026.09.033_bib5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.033_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jmb.2019.11.016","article-title":"Nucleic Acid Sensors and Programmed Cell Death","volume":"432","author":"Maelfait","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41573-019-0043-2","article-title":"Pharmacological modulation of nucleic acid sensors \u2014 therapeutic potential and persisting obstacles","volume":"18","author":"Vanpouille-Box","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.09.033_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41586-022-05545-9","article-title":"R-loop-derived cytoplasmic RNA\u2013DNA hybrids activate an immune response","volume":"613","author":"Crossley","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.033_bib10","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2017.09.039","article-title":"The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3","volume":"171","author":"Gaidt","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.09.033_bib11","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41591-021-01387-6","article-title":"Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2","volume":"27","author":"Au","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.09.033_bib12","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1016\/S2665-9913(21)00221-6","article-title":"Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study","volume":"3","author":"Felten","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11926-021-01046-2","article-title":"The Use of COVID-19 Vaccines in Patients with SLE","volume":"23","author":"Tang","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ymthe.2026.09.033_bib14","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1038\/s41375-021-01354-7","article-title":"Response to mRNA vaccination for COVID-19 among patients with multiple myeloma","volume":"35","author":"Stampfer","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2026.09.033_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molmed.2019.10.002","article-title":"Tailoring mRNA Vaccine to Balance Innate\/Adaptive Immune Response","volume":"26","author":"Linares-Fern\u00e1ndez","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2026.09.033_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","article-title":"Algorithm for optimized mRNA design improves stability and immunogenicity","volume":"621","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.033_bib17","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.cell.2025.05.032","article-title":"Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement","volume":"188","author":"B\u00e9routi","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.09.033_bib18","article-title":"The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old","volume":"89","author":"McLeod","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.ymthe.2026.09.033_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymthe.2024.01.013","article-title":"A new immune pathway mediating AAV immune responses","volume":"32","author":"Chan","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.033_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.08.021","article-title":"High-titer AAV disrupts cerebrovascular integrity and induces lymphocyte infiltration in adult mouse brain","volume":"31","author":"Guo","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.09.033_bib21","series-title":"The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list","year":"2025"},{"key":"10.1016\/j.ymthe.2026.09.033_bib22","article-title":"Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons","volume":"1","author":"Rother","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymthe.2026.09.033_bib23","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines","volume":"186","author":"Ku\u017enik","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib24","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.3390\/molecules25225318","article-title":"Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review","volume":"25","author":"Faraone","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ymthe.2026.09.033_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113834","article-title":"Nucleic acid delivery for therapeutic applications","volume":"178","author":"Gupta","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2026.09.033_bib26","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/jcb.10477","article-title":"Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts","volume":"88","author":"Xu","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ymthe.2026.09.033_bib27","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1038\/s41467-024-51411-9","article-title":"Innate immune responses against mRNA vaccine promote cellular immunity through IFN-\u03b2 at the injection site","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.033_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/jpet.120.000385","article-title":"Physiologically Based Pharmacokinetics of Lysosomotropic Chloroquine in Rat and Human","volume":"376","author":"Liu","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2026.09.033_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2026.102948","article-title":"Biodistribution of mRNA vaccines in rats: Enrichment in injection site and lymph tissues and rapid clearance without tissue persistence","volume":"37","author":"Goody","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.09.033_bib31","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1021\/acs.molpharmaceut.2c01024","article-title":"Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection","volume":"20","author":"Takanashi","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2026.09.033_bib32","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.4049\/jimmunol.179.3.1942","article-title":"IFN-gamma-mediated survival enables human neutrophils to produce MCP-1\/CCL2 in response to activation by TLR ligands","volume":"179","author":"Yoshimura","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.132","article-title":"Blockade of mIL-6R alleviated lipopolysaccharide-induced systemic inflammatory response syndrome by suppressing NF-\u03baB-mediated Ccl2 expression and inflammasome activation","volume":"3","author":"Dai","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.ymthe.2026.09.033_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4582612","article-title":"Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine","volume":"2020","author":"Richard","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ymthe.2026.09.033_bib35","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.09.033_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41434-023-00405-1","article-title":"Adeno-associated virus vectors and neurotoxicity\u2014lessons from preclinical and human studies","volume":"32","author":"Stone","year":"2025","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.09.033_bib37","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.ymthe.2024.03.036","article-title":"An innate immune response to adeno-associated virus genomes decreases cortical dendritic complexity and disrupts synaptic transmission","volume":"32","author":"Suriano","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.033_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.09.018","article-title":"Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption","volume":"196","author":"Foley","year":"2014","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2026.09.033_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.09.001","article-title":"Breaching the blood-brain barrier: AAV triggers dose-dependent toxicity in the brain","volume":"31","author":"Stone","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.09.033_bib40","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41551-025-01399-4","article-title":"Treatment of a metabolic liver disease in mice with a transient prime editing approach","volume":"9","author":"Rothgangl","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.09.033_bib41","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","article-title":"In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels","volume":"39","author":"Rothgangl","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.09.033_bib43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/13543784.2024.2369747","article-title":"VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol","volume":"33","author":"Hooper","year":"2024","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ymthe.2026.09.033_bib44","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease","volume":"392","author":"Musunuru","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.09.033_bib45","article-title":"A base editing strategy using mRNA-LNPs for in vivo correction of the most frequent phenylketonuria variant","volume":"5","author":"Brooks","year":"2024","journal-title":"HGG Adv."},{"key":"10.1016\/j.ymthe.2026.09.033_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.09.033_bib47","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.3390\/ijms21144972","article-title":"Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy","volume":"21","author":"Chandler","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.09.033_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/eji.202149361","article-title":"Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells","volume":"52","author":"Cenac","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116150","article-title":"Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways","volume":"44","author":"Rennen","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.09.033_bib50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/imm.13835","article-title":"Hydroxychloroquine attenuates double-stranded RNA-stimulated hyper-phosphorylation of tristetraprolin\/ZFP36 and AU-rich mRNA stabilization","volume":"173","author":"Hitti","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.ymthe.2026.09.033_bib51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fimmu.2019.00275","article-title":"Effect of in vivo Hydroxychloroquine and ex vivo Anti-BDCA2 mAb Treatment on pDC IFN\u03b1 Production From Patients Affected With Cutaneous Lupus Erythematosus","volume":"10","author":"Gardet","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib52","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1039\/D4CC06659F","article-title":"The time course of in vivo cellular responses to LNPs","volume":"61","author":"Loughrey","year":"2025","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ymthe.2026.09.033_bib53","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1038\/mtna.2012.28","article-title":"Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA","volume":"1","author":"Belliveau","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.09.033_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"Embnet. J."},{"key":"10.1016\/j.ymthe.2026.09.033_bib55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.09.033_bib57","author":"Blighe"},{"key":"10.1016\/j.ymthe.2026.09.033_bib58","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.09.033_bib59","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/bioinformatics\/btw191","article-title":"flowAI: automatic and interactive anomaly discerning tools for flow cytometry data","volume":"32","author":"Monaco","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.09.033_bib60","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/vaccines9050431","article-title":"A nanoscaffolded spike-rbd vaccine provides protection against sars-cov-2 with minimal anti-scaffold response","volume":"9","author":"Lain\u0161\u010dek","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2026.09.033_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J. Immunol. Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600804X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600804X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:42:21Z","timestamp":1792010541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162600804X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":61,"alternative-id":["S152500162600804X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.033","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoupling reactogenicity from efficacy enables safer mRNA vaccines, AAV gene delivery, and in vivo base editing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}